Serum ADAM17 levels pre-antiviral therapy correlate with HIV patient immune reconstitution
Background: The relationship between tumour necrosis factor (TNF) levels and disease progression is well-established. However, the impact of changes in the level of TNF hydrolase (A-disintegrin and metalloenzyme 17; ADAM17) in HIV patients remains to be fully elucidated. Methods: Between March 1 and...
Saved in:
| Main Authors: | Ying Lin, Ming Chen, Xuelian Zhu, xiaoya cui, Suyu Sun, Xingzhong Hu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Heliyon |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024167655 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A disintegrin and metallopeptidase domain (ADAM) 12, ADAM 17 mRNA and ADAM10 protein hold potential as biomarkers for detection of early gastric cancer
by: Sooyeon Oh, et al.
Published: (2025-01-01) -
Updates on Inflammatory Molecular Pathways Mediated by ADAM17 in Autoimmunity
by: Margherita Sisto, et al.
Published: (2024-12-01) -
Inhibiting ADAM17 enhances the efficacy of olaparib in ovarian cancer spheroids
by: Christoph Rogmans, et al.
Published: (2024-11-01) -
ADAM17 selectively activates the IL‐6 trans‐signaling/ERK MAPK axis in KRAS‐addicted lung cancer
by: Mohamed I Saad, et al.
Published: (2019-03-01) -
Therapeutic Potential of Qilianxiaopi Formula: Targeting ADAM17-Mediated Chronic Inflammation in Atrophic Gastritis
by: Sijing Du, et al.
Published: (2025-03-01)